128 related articles for article (PubMed ID: 23024806)
1. IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.
Ruhwald M; Andersen ES; Christensen PB; Moessner BK; Weis N
PLoS One; 2012; 7(9):e45181. PubMed ID: 23024806
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection.
Chalin A; Lefevre B; Devisme C; Barget N; Amiot L; Samson M
Cytokine; 2019 May; 117():72-78. PubMed ID: 30826602
[TBL] [Abstract][Full Text] [Related]
3. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
4. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
[TBL] [Abstract][Full Text] [Related]
5. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.
Zeremski M; Dimova R; Astemborski J; Thomas DL; Talal AH
J Infect Dis; 2011 Sep; 204(6):832-6. PubMed ID: 21849280
[TBL] [Abstract][Full Text] [Related]
6. Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study.
Salgüero S; Medrano LM; González-García J; Berenguer J; Montes ML; Diéz C; Garcia-Broncano P; Llop-Herrera E; Pérez-Latorre L; Bellóno JM; Jiménez-Sousa MÁ; Resino S
Sci Rep; 2020 Jun; 10(1):10384. PubMed ID: 32587340
[TBL] [Abstract][Full Text] [Related]
7. IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.
El Raziky M; Elsharkawy A; Said SE; Abdelatty S; El Akel W; Tantawy O; Gamal Eldeen H; Mabrouk M
J Interferon Cytokine Res; 2015 Aug; 35(8):649-53. PubMed ID: 25973761
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection.
Khalifa KA; Radwan WM; Attallah KM; Hosney H; Eed EM
Acta Gastroenterol Belg; 2014 Dec; 77(4):401-7. PubMed ID: 25682629
[TBL] [Abstract][Full Text] [Related]
9. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
10. IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting.
Hoel IM; Jørstad MD; Marijani M; Ruhwald M; Mustafa T; Dyrhol-Riise AM
Sci Rep; 2019 Mar; 9(1):3871. PubMed ID: 30846768
[TBL] [Abstract][Full Text] [Related]
11. IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.
Tonby K; Ruhwald M; Kvale D; Dyrhol-Riise AM
Sci Rep; 2015 Mar; 5():9223. PubMed ID: 25783975
[TBL] [Abstract][Full Text] [Related]
12. Use of IP-10 detection in dried plasma spots for latent tuberculosis infection diagnosis in contacts via mail.
Villar-Hernández R; Latorre I; De Souza-Galvão ML; Jiménez MA; Ruiz-Manzano J; Pilarte J; García-García E; Muriel-Moreno B; Cantos A; Altet N; Millet JP; González-Díaz Y; Molina-Pinargote I; Prat C; Ruhwald M; Domínguez J
Sci Rep; 2019 Mar; 9(1):3943. PubMed ID: 30850687
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.
Sevgi DY; Bayraktar B; Gündüz A; Özgüven BY; Togay A; Bulut E; Uzun N; Dökmetaş İ
Wien Klin Wochenschr; 2016 Jan; 128(1-2):28-33. PubMed ID: 26546355
[TBL] [Abstract][Full Text] [Related]
14. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper.
Aabye MG; Latorre I; Diaz J; Maldonado J; Mialdea I; Eugen-Olsen J; Ravn P; Dominguez J; Ruhwald M
Eur Respir J; 2013 Aug; 42(2):495-503. PubMed ID: 23349445
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
Benbow JH; Elam AD; Bossi KL; Massengill DL; Brandon-Warner E; Anderson WE; Culberson CR; Russo MW; deLemos AS; Schrum LW
Dig Dis Sci; 2018 Mar; 63(3):653-664. PubMed ID: 29330728
[TBL] [Abstract][Full Text] [Related]
16. Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail.
Neesgaard B; Ruhwald M; Krarup HB; Weis N
PLoS One; 2018; 13(7):e0201629. PubMed ID: 30063765
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
[TBL] [Abstract][Full Text] [Related]
18. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.
Reiberger T; Aberle JH; Kundi M; Kohrgruber N; Rieger A; Gangl A; Holzmann H; Peck-Radosavljevic M
Antivir Ther; 2008; 13(8):969-76. PubMed ID: 19195322
[TBL] [Abstract][Full Text] [Related]
19. PREDICTIVE VALUE OF SERUM IL-17A AND IP-10 FOR EVALUATION OF LIVER FIBROSIS PROGRESSION IN PATIENTS WITH HBV/HIV CO-INFECTION.
Moroz L; Soni S; Dudnyk V; Zaichko N
Georgian Med News; 2019 May; (290):73-77. PubMed ID: 31322519
[TBL] [Abstract][Full Text] [Related]
20. Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
Sherman KE; Abdel-Hameed EA; Ehman RL; Rouster SD; Campa A; Martinez SS; Huang Y; Zarini GG; Hernandez J; Teeman C; Tamargo J; Liu Q; Mandler R; Baum MK
Dig Dis Sci; 2020 Apr; 65(4):1252-1257. PubMed ID: 31468264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
